Epicutis Appoints James Y. Wang as Chief Medical Officer
Biotechnology skincare brand Epicutis has appointed James Y. Wang, MD, MBA, as its new Chief Medical Officer. Wang previously chaired the company's Scientific Advisory Board.
Epicutis, a professional skincare company utilizing biotechnology, has appointed James Y. Wang, MD, MBA, to the role of Chief Medical Officer. Wang transitions to this executive position from his prior role as Chairman of the company's Scientific Advisory Board.
In his new capacity, Wang will be responsible for overseeing the company's medical strategy, clinical research initiatives, and professional education programs. This appointment aligns with Epicutis's growth phase as the brand seeks to expand its market presence.
Wang brings a background combining medical expertise with business acumen. He holds both an MD and an MBA, and has previous experience in various leadership positions within the healthcare sector.
The company, Epicutis, focuses on developing professional skincare products driven by scientific research and innovation in biotechnology.